References
- Zapf J. Role of Insulin like Growth factors (IGF II) and IGF binding proteins in extrapancreatic tumour hypoglycaemia. Journal of Internal Medicine 1993; 234: 543–52
- Zapf J. Insulin like growth factors binding protein and tumour hypoglycaemia. Trends in Endocrinology and Metabolism 1995; 6: 37–42
- Marks V, Teale JD. Investigation of Hypoglycaemia. Clinical endocrinology 1996; 44: 133–6
- Marks V, Teale JD. Inappropriately elevated plasma insulin like Growth Factor II in relation to suppressed insulin like growth factor I in the diagnosis of Non Islet cell tumour. Hypoglycaemia Clinical Endocrinology 1990; 33: 87–8
- Baxter RC. The role of insulin like growth factors and their binding proteins in tumour hypoglycaemia. Hormone Research 1996; 46: 195–201
- Bertherat J, Logie A, Gicquel C, Mourrieras F, Luton JP, Le Bouc Y. Alteration of 11p15 imprint region s and the IGF system in a case of recurrent non-islet tumour hypoglycaemia (NICTH). Clinical Endocrinology 2000; 53: 213–20
- Werner H, Le Roith D. New concepts in regulation and function of insulin like growth factors: implication for understanding normal growth and neoplasm. Cell Mol Life Sci 2000; 57(6): 932–942
- Hoekman K, van Doorn J, Gloudemans T, Massen JA, Schuller AGP, Pinedo HM. Hypoglycaemia associated with production of insulin like growth factor II and insulin like growth factor binding protein 6 by a haemangiopericytoma. Clinical Endocrinology 1999; 51: 247–253
- Baxter RC, Daughaday WH. Impaired formation of ternary insulin like growth factor binding protein complex in-patients with hypoglycaemia due to non-islet cell tumours. Journal of Clinical Endocrinology and Metabolism 1991; 73: 696–702
- Marks, V. Colour Atlas of Clinical Endocrinology. Mosby Wolfe Medical Communications 1998;20.1–20.18.
- Teale JD, Marks V. Glucocorticoid therapy suppresses abnormal secretion of big IGF II by non islet cell tumour inducing hypoglycaemia (NICTH). Clinical Endocrinology 1998; 49: 491–98
- Teale, JD, Blum, WF, Marks, V. Alleviation of non islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein 3. Annals of Clinical Biochemistry 1992;29:314–23.
- Khaleeli A, Perumainar M, Spedding AV, Teale JD, Marks V. Treatment of tumour induced hypoglycaemia with human growth hormone. Journal of Royal Society of Medicine 1992; 85: 303
- Papadimitris C, Alvizaki M, Pantazopoulos D, Nakapoulou L, Athanassiades P, Dimopoulos MA. Cushing syndrome as the presenting feature of metastatic Leydig cell tumour of testis. Urology 2000; 56: 153
- McNulty, SJ, Furlong, N, Al-Jubouri, MA, Hardy, KJ. Dexamethasone-treatment of choice in IGF 2 mediated non islet cell tumour hypoglycaemia?. Journal of Endocrinology 1998;156, (Suppl.):44.
- Marks V, Teale JD. Tumours producing hypoglycaemia. Diabetes/ Metabolism Revs. 1991; 7: 79–91